Available Covid-19 Tests
TYPE OF TEST | ACTIVE INFECTION TEST | IMMUNE RESPONSE TEST |
Testing Platform
|
(1) BioGX
SARS-CoV-2 Assay for the BD MAX System
(2) Biofire
Respiratory Panel 2.1 (RP2.1) |
Abbott
Architect SARS-CoV-2 IgG
|
Technology
|
(1) Real
Time – Polymerase Chain Reaction (RT-PCR)
(2) Multiplex
RT-PCR |
Chemiluminescent
Microparticle Immunoassay (CMIA)
|
Target
|
RNA
from the nucleocapsid phosphoprotein gene (N1 and N2 regions) of the SARS-CoV-2
|
Nucleocapsid
|
Use
|
The
CoVID-19 Active infection Test is for those who suspect they may be currently
infected with CoVID-19 because they are experiencing symptoms or have been
exposed to someone confirmed to have CoVID-19.
|
The
antibody test is for those who don’t currently feel sick and have not
experienced any symptoms in at least 10 days, but want to find out if they have
previously been infected and recovered from CoVID-19.
|
Specimen
Type
|
Nasopharyngeal
Swab
|
Plasma
via Blood Draw
|
Results
Availability
|
Results
typically available within 1 day
|
Results
typically available within 1 day
|
Performance
|
Data
published on the US-FDA’s website suggest this test has Sensitivity (PPA) of
100% and Specificity (NPA) of 100%; MCCH internal study using clinical
specimens revealed a Sensitivity and Specificity of 100%; although it should
not be assumed the test is 100% accurate over an infinite sample size.
|
Data
published on the US-FDA’s website suggest this test has a sensitivity (PPA) of
100% and specificity (NPA) of 99.6%; MCCH internal study using clinical
specimens revealed a Sensitivity and Specificity of 100%; although it should
not be assumed the test is 100% accurate over an infinite sample size.
|
PPA = Positive Percent Agreement; NPA = Negative Percent
Agreement
|
|
|
Frequently Asked Questions | FAQs
What types of testing are you offering?
MCCH Clinical Laboratory is offering 2 types of CoVID-19 Testing:
- Active Infection Test
MCCH Clinical Laboratory is offering services for the BioGX SARS-CoV-2 Assay for the BD MAX System (RT-PCR). This test has been issued Emergency Use Authorization by the US-FDA. This test is not yet approved or cleared by the US-FDA. When there are no FDA-approved or cleared tests available, and other criteria are met, FDA can make tests available under an emergency access mechanism called an Emergency Use Authorization (EUA).
A swab is inserted into one nostril to the nasopharynx. The swab is then rotated in a circle around the entire inside of the nasopharynx at least five times. Test results are typically sent to the ordering provider/facility within 1 day.
- Immune Response Test
MCCH Clinical Laboratory is offering services for the Abbott Architect SARS-CoV-2 IgG Antibody test. This test has been issued Emergency Use Authorization by the US-FDA. This test is not yet approved or cleared by the US-FDA. When there are no FDA-approved or cleared tests available, and other criteria are met, FDA can make tests available under an emergency access mechanism called an Emergency Use Authorization (EUA).
A blood sample is collected via a blood draw from the patient’s arm and results are typically sent to the ordering provider/facility within 1 day.
What is the difference between the tests?
The Active Infection Test helps to diagnose whether you currently have an active CoVID-19 infection. A diagnosis can guide you and your doctor or healthcare provider to make an informed decision about self-quarantining to protect your family, friends and our community. Active infection testing may be right for you if you are currently experiencing CoVID-19 symptoms or were exposed to the virus in the last 14 days. Common CoVID-19 symptoms include fever, cough, and shortness of breath.
The Immune Response Test is the test detects antibodies that show if you have already been exposed to and produced an immune response to CoVID-19 even if you never experienced symptoms. Previous exposure means you may now have some level of immunity to the virus. Understanding your immune response gives you and your doctor or healthcare provider the information to assist in making an informed decision about returning to work or activity. Immune response testing is available only to patients who are not currently experiencing CoVID-19 symptoms and have not experienced symptoms within 14 days.
Where are the tests processed?
Both the active infection test and immune response offered at MCCH Clinical Laboratory are processed and tested in-house (Bridgeport, NE).
Will the test results be reported to the Panhandle Public Health Department?
Yes, all results will be reported to PPHD and Nebraska Department of Health and Human Services.
Is MCCH Clinical Laboratory certified, permitted to perform CoVID-19 Testing?
Yes, MCCH Clinical Laboratory is fully compliant and accredited by COLA and CLIA to perform moderate and highly complex laboratory tests.
How accurate is your test methodologies?
Data published on the US-FDA’s website suggest that the BioGX SARS-CoV-2 Assay on the BD MAX System has Sensitivity (Positive Percent Agreement) of 100% and Specificity (Negative Percent Agreement) of 100%; MCCH internal study using clinical specimens revealed a Sensitivity and Specificity of 100%; although it should not be assumed the test is 100% accurate over an infinite sample size.
Data published on the US-FDA’s website suggest that Abbott Architect SARS-CoV-2 IgG Antibody test has a sensitivity (PPA) of 100% and specificity (NPA) of 99.6%; MCCH internal study using clinical specimens revealed a Sensitivity and Specificity of 100%; although it should not be assumed the test is 100% accurate over an infinite sample size.Will insurance pay for CoVID-19 tests?
Please refer to your insurance plan for coverage details.